Effect of prehospital treatment in STEMI patients undergoing primary PCI.

ABSTRACT:

Background

The appropriate timing to administer antithrombotic therapies in ST-elevation myocardial infarction (STEMI) remains uncertain. This study aims to evaluate the role of antithrombotic therapy administration at first medical contact (FMC) compared with the administration in the Cathlab.

Methods

We conducted a "before-after" observational study enrolling STEMI undergoing primary percutaneous coronary intervention (PCI). Outcomes were evaluated during two successive periods, before (control group: aspirin only at FMC) and after (pretreated intervention group: heparin, aspirin plus ticagrelor at FMC) the introduction of a new regional pretreatment protocol.

Results

A total of 537 consecutive patients (300 in control vs. 237 in intervention group) were enrolled. T

SUBMITTER: Fabris E 

PROVIDER: S-EPMC9546098 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature